Cas:69658-13-5 2-(7-oxobenzo[a]phenalen-3-yl)sulfanylacetic acid manufacturer & supplier

Chemical Name:2-(7-oxobenzo[a]phenalen-3-yl)sulfanylacetic acid

CAS.NO:69658-13-5

Synonyms:3-Benzanthronyl carboxymethyl sulfide;3-Carboxymethylbenzanthrone

Molecular Formula:C₁₉H₁₂O₃S

Molecular Weight:320.36200

HS Code:2930909090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:595.9ºC at 760 mmHg

Density:1.46g/cm3

Index of Refraction:1.769

PSA:79.67000

Exact Mass:320.05100

LogP:4.22790

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3-Benzanthronyl carboxymethyl sulfide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Carboxymethylbenzanthrone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Carboxymethylbenzanthrone Use and application,3-Benzanthronyl carboxymethyl sulfide technical grade,usp/ep/jp grade.

Related News: China will use its national drug bulk-buy scheme to lower the price of drugs currently sold at higher prices compared with other markets, it said in an official statement. 2-(7-oxobenzo[a]phenalen-3-yl)sulfanylacetic acid manufacturer China will use its national drug bulk-buy scheme to lower the price of drugs currently sold at higher prices compared with other markets, it said in an official statement. 2-(7-oxobenzo[a]phenalen-3-yl)sulfanylacetic acid supplier China will use its national drug bulk-buy scheme to lower the price of drugs currently sold at higher prices compared with other markets, it said in an official statement. 2-(7-oxobenzo[a]phenalen-3-yl)sulfanylacetic acid vendor China will use its national drug bulk-buy scheme to lower the price of drugs currently sold at higher prices compared with other markets, it said in an official statement. 2-(7-oxobenzo[a]phenalen-3-yl)sulfanylacetic acid factory In August, the Company announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,370,452 covering compositions and uses of effector T cells expressing a CAR, where such T cells are derived from a pluripotent stem cell, including an iPSC.